MedPath

Effect of sildenafil citrate on endometrial preparation and on the outcome of the frozen-thawed embryo transfer cycles

Phase 2
Conditions
Female Infertility.
Complications of attempted introduction of embryo in embryo transfer
Registration Number
IRCT201210232575N3
Lead Sponsor
Yazd Shahid Sadoughi University of Medical Sciences and Health Services, Vice Chancellor for resear
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
80
Inclusion Criteria

Inclusion criteria:
All infertile women have high quality frozen embryos.

Exclusion criteria:
1. Age> 40
2. History of endocrine disease such as: diabetes; Hyperthyroidism and Hyperprolactinemia
3. History of hysteroscopic surgery due to intrauterine adhesions
4. History of cardiovascular, renal or liver disease
5. Hypotension( blood pressure<90/50)
6. History of stroke or myocardial infarction
7. Poor quality embryos
8. Alcohol or Substance abuse

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Endometrial thickness. Timepoint: ?Within a day from 13th day of the menstrual cycle. Method of measurement: Vaginal sonoghraphy.;Chemical pregnancy. Timepoint: Two weeks after embryo transfer. Method of measurement: BHCG test.
Secondary Outcome Measures
NameTimeMethod
Duration of infertility. Timepoint: Before intervention. Method of measurement: Patient's medical record.;Implantation rate. Timepoint: Four weeks after the embryo transfer. Method of measurement: Number of gestational sac are determined by vaginal ultrasound.;FSH, LH, FSH/LH level. Timepoint: ratio in progesterone day administration. Method of measurement: Blood sample.
© Copyright 2025. All Rights Reserved by MedPath